The present demonstration that long-term treatment with CsA ameliorates performance in specific muscles of 5 out 6 UCMD patients and improves regeneration is an encouraging result that raises some hope for the use of cyclophilin inhibitors for the cure of this and possibly other muscle diseases. This evidence concerns the gene PPIB and Ullrich congenital muscular dystrophy.